High Salt Intake Is Independently Associated With Hypertensive Target Organ Damage

Journal of Clinical Hypertension

Volumn 18, Issue 4, 2016, Pages 315-321

  Imaizumi, Yuki ^a   Eguchi, Kazuo ^a   Murakami, Takeshi ^b   Arakawa, Kimika ^c   Tsuchihashi, Takuya ^d   Kario, Kazuomi ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

^b Munakata Ohshima Clinic   (Japan)

^c NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^d STEEL MEMORIAL YAWATA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

8 HYDROXYDEOXYGUANOSINE; BIOLOGICAL MARKER; SALT INTAKE; SODIUM CHLORIDE;

AGED; ALBUMIN CREATININE RATIO; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIASTOLIC BLOOD PRESSURE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; ORGAN CIRCULATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SALT INTAKE; SODIUM EXCRETION; SYSTOLIC BLOOD PRESSURE; TARGET ORGAN DAMAGE; URINALYSIS; ADVERSE EFFECTS; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; DRUG EFFECTS; FOLLOW UP; JAPAN; MORBIDITY; PHARMACOKINETICS; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TRENDS; URINE;

AGED; BIOMARKERS; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERTENSION; JAPAN; MALE; MORBIDITY; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SODIUM CHLORIDE; SODIUM CHLORIDE, DIETARY; SURVIVAL RATE;

EID: 84945151316     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12668     Document Type: Article

References (45)

1. Mozaffarian D, Fahimi S, Singh GM, et al. Global sodium consumption and death from cardiovascular causes. N Engl J Med. 2014;371:624-634.
2. Intersalt Cooperative Research Group. Intersalt: an international study of electrolyte excretion and blood pressure. Results for 24 hour urinary sodium and potassium excretion. BMJ. 1988;297:319-328.
3. He J, Ogden LG, Vupputuri S, et al. Dietary sodium intake and subsequent risk of cardiovascular disease in overweight adults. JAMA. 1999;282:2027-2034.
4. Tuomilehto J, Jousilahti P, Rastenyte D, et al. Urinary sodium excretion and cardiovascular mortality in Finland: a prospective study. Lancet. 2001;357:848-851.
5. Sacks FM, Svetkey LP, Vollmer WM, et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet. DASH-Sodium Collaborative Research Group. N Engl J Med. 2001;344:3-10.
6. Cook NR, Appel LJ, Whelton PK. Lower levels of sodium intake and reduced cardiovascular risk. Circulation. 2014;129:981-989.
7. Farquhar WB, Edwards DG, Jurkovitz CT, Weintraub WS. Dietary sodium and health: more than just blood pressure. J Am Coll Cardiol. 2015;65:1042-1050.
8. Avolio AP, Clyde KM, Beard TC, et al. Improved arterial distensibility in normotensive subjects on a low salt diet. Arteriosclerosis. 1986;6:166-169.
9. Seta H, Ishimitsu T, Tamano K, et al. Increase in left ventricular mass is influenced by blood pressure and obesity, whereas reduction in left ventricular diastolic function is affected by greater age and salt intake. J Cardiol. 2001;37:249-256.
10. Engelen L, Soedamah-Muthu SS, Geleijnse JM, et al. Higher dietary salt intake is associated with microalbuminuria, but not with retinopathy in individuals with type 1 diabetes: the EURODIAB Prospective Complications Study. Diabetologia. 2014;57:2315-2323.
11. Zhu J, Huang T, Lombard JH. Effect of high-salt diet on vascular relaxation and oxidative stress in mesenteric resistance arteries. J Vasc Res. 2007;44:382-390.
12. Dobrian AD, Schriver SD, Lynch T, Prewitt RL. Effect of salt on hypertension and oxidative stress in a rat model of diet-induced obesity. Am J Physiol Renal Physiol. 2003;285:F619-F628.
13. Suzuki K, Honjo H, Ichino N, et al. Association of serum carotenoid levels with urinary albumin excretion in a general Japanese population: The Yakumo Study. J Epidemiol. 2013;23:451-456.
14. http://www.dableducational.org/sphygmomanometers/devices_2_sbpm.html.
15. Ogihara T, Kikuchi K, Matsuoka H, et al. Japanese Society of Hypertension Committee. The Japanese Society of Hypertension Guidelines for the Management of Hypertension (JSH 2009). Hypertens Res. 2009;32:3-107.
16. Tanaka T, Okamura T, Miura K, et al. A simple method to estimate populational 24-h urinary sodium and potassium excretion using a casual urine specimen. J Hum Hypertens. 2002;16:97-103.
17. Mente A, O'Donnell MJ, Dagenais G, et al. Validation and comparison of three formulae to estimate sodium and potassium excretion from a single morning fasting urine compared to 24-h measures in 11 countries. J Hypertens. 2014;32:1005-1014.
18. Kawasaki T, Itoh K, Uezono K, Sasaki H. A simple method for estimating 24 h urinary sodium and potassium excretion from second morning voiding urine specimen in adults. Clin Exp Pharmacol Physiol 1993;20:7-14.
19. Floyd RA, Watson JJ, Wong PK, et al. Hydroxyl free radical adduct of deoxyguanosine: sensitive detection and mechanisms of formation. Free Radical Res. 1986;1:163-172.
20. Kushiro T, Fujita H, Hisaki R, et al. Oxidative stress in the Dahl salt-sensitive hypertensive rat. Clin Exp Hypertens. 2005;27:9-15.
21. Matsumoto Y, Ogawa Y, Yoshida R, et al. The stability of the oxidative stress marker, urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG), when stored at room temperature. J Occup Health. 2008;50:366-372.
22. http://www.jaica.com/guidance:8ohdg/.
23. DuPont JJ, Greaney JL, Wenner MM, et al. High dietary sodium intake impairs endothelium-dependent dilation in healthy salt-resistant humans. J Hypertens. 2013;31:530-536.
24. Yilmaz R, Akoglu H, Altun B, et al. Dietary salt intake is related to inflammation and albuminuria in primary hypertensive patients. Eur J Clin Nutr. 2012;66:1214-1218.
25. Lüscher TF, Tanner FC, Tschudi MR, Noll G. Endothelial dysfunction in coronary artery disease. Annu Rev Med. 1993;44:395-418.
26. Boegehold MA. The effect of high salt intake on endothelial function: reduced vascular nitric oxide in the absence of hypertension. J Vasc Res. 2013;50:458-467.
27. Nijst P, Verbrugge FH, Grieten L, et al. The pathophysiological role of interstitial sodium in heart failure. J Am Coll Cardiol. 2015;65:378-388.
28. Bhagatwala J, Harris RA, Parikh SJ, et al. Epithelial sodium channel inhibition by amiloride on blood pressure and cardiovascular disease risk in young prehypertensives. J Clin Hypertens (Greenwich). 2014;16:47-53.
29. Edwards DG, Farquhar WB. Vascular effects of dietary salt. Curr Opin Nephrol Hypertens. 2015;1:8-13. doi:10.1097/MNH.0000000000000089.
30. Lenda DM, Sauls BA, Boegehold MA. Reactive oxygen species may contribute to reduced endothelium-dependent dilation in rats fed high salt. Am J Physiol Heart Circ Physiol. 2000;279:7-17.
31. Lenda DM, Boegehold MA. Effect of a high salt diet on microvascular antioxidant enzymes. J Vasc Res. 2002;39:41-50.
32. Oberleithner H, Riethmüller C, Schillers H, et al. Plasma sodium stiffens vascular endothelium and reduces nitric oxide release. Proc Natl Acad Sci USA. 2007;104:16281-16286.
33. Weinberger MH, Miller JZ, Luft FC, et al. Definitions and characteristics of sodium sensitivity and blood pressure resistance. Hypertension. 1986;8:127-134.
34. Weinberger MH, Fineberg NS, Fineberg SE, Weinberger M. Salt sensitivity, pulse pressure, and death in normal and hypertensive humans. Hypertension. 2001;37:429-432.
35. Weinberger MH, Fineberg NS. Sodium and volume sensitivity of blood pressure. Age and pressure change over time. Hypertension. 1991;18:67-71.
36. Hunt SC, Xin Y, Wu LL, et al. Sodium bicarbonate cotransporter polymorphisms are associated with baseline and 10-year follow-up blood pressures. Hypertension. 2006;47:532-536.
37. Carey RM, Schoeffel CD, Gildea JJ, et al. Salt sensitivity of blood pressure is associated with polymorphisms in the sodium-bicarbonate cotransporter. Hypertension. 2012;60:1359-1366.
38. Bertorello AM, Pires N, Igreja B, et al. Increased arterial blood pressure and vascular remodeling in mice lacking salt-inducible kinase 1 (SIK1). Circ Res. 2015;116:642-652.
39. Popov S, Silveira A, Wågsäter D, et al. Salt-inducible kinase 1 influences Na(+), K(+)-ATPase activity in vascular smooth muscle cells and associates with variations in blood pressure. J Hypertens. 2011;29:2395-2403.
40. Cao Y, Mu JJ, Fang Y, et al. Impact of high salt independent of blood pressure on PRMT/ADMA/DDAH pathway in the aorta of Dahl salt-sensitive rats. Int J Mol Sci. 2013;14:8062-8072.
41. Foulquier S, Dupuis F, Perrin-Sarrado C, et al. High salt intake abolishes AT(2)-mediated vasodilation of pial arterioles in rats. J Hypertens 2011;29:1392-1399.
42. Guzik TJ, Hoch NE, Brown KA, et al. Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction. J Exp Med 2007;204:2449-2460.
43. Kleinewietfeld M, Manzel A, Titze J, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature 2013;496:518-522.
44. Amador CA, Barrientos V, Peña J, et al. Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes. Hypertension. 2014;63:797-803.
45. Mann SJ, Gerber LM. Estimation of 24-hour sodium excretion from spot urine samples. J Clin Hypertens (Greenwich). 2010;12:174-180.